EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment

Miki Takenaka Sato iD, Takuya Araki iD, Hideaki Yashima iD, Yuya Ishikawa, Jun Morita iD, Yoshiko Maeda iD, Masayuki Ohbayashi iD, Noriko Kohyama iD, Yoshio Ogawa iD, Takashi Fukagai iD, Koujirou Yamamoto, Mari Kogo iD

Cancer Chemotherapy and Pharmacology · 2025-12 · 95 (1)

DOI: 10.1007/s00280-024-04741-w ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 26.12.2024. Verfasst von Miki Takenaka Sato und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacotherapeutics, Department of Clinical Pharmacy, School of Pharmacy, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-85…. Hauptthemen laut MEDLINE: Sunitinib, Carcinoma, Renal Cell, Kidney Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SunitinibCarcinoma, Renal CellKidney NeoplasmsAntineoplastic AgentsHumansMaleFemaleMiddle AgedAgedProspective StudiesProtein Kinase InhibitorsAdult

Stichwörter der Autor:innen

Long-term treatmentMetabolitesMetastatic renal cell carcinomaSunitinibTherapeutic drug monitoring

Substanzen

SunitinibAntineoplastic AgentsProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Division of Pharmacotherapeutics, Department of Clinical Pharmacy, School of Pharmacy, Showa University, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan. m-takenaka@pharm.showa-u.ac.jp.
  • Department of Clinical Pharmacology and Therapeutics, Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Department of Pharmacy, Gunma University Hospital, Maebashi, Japan.
  • Department of Urology, Showa University Hospital, Tokyo, Japan.
  • Department of Urology, Showa University Fujigaoka Hospital, Yokohama, Japan.
  • Pelvic Reconstructive Surgery, Tokyo Women's Medical University, Adachi Medical Center, Tokyo, Japan.

ORCID-Profile: Miki Takenaka Sato, Takuya Araki, Hideaki Yashima, Jun Morita, Yoshiko Maeda, Masayuki Ohbayashi, Noriko Kohyama, Yoshio Ogawa, Takashi Fukagai, Mari Kogo

Zitieren

APA

Sato, M. T., Araki, T., Yashima, H., Ishikawa, Y., Morita, J., Maeda, Y., Ohbayashi, M., Kohyama, N., Ogawa, Y., Fukagai, T., Yamamoto, K., & Kogo, M. (2025). Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment. Cancer Chemotherapy and Pharmacology, 95(1). https://doi.org/10.1007/s00280-024-04741-w

Vancouver

Sato MT, Araki T, Yashima H, Ishikawa Y, Morita J, Maeda Y, et al. Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment. Cancer Chemotherapy and Pharmacology. 2025;95(1). doi:10.1007/s00280-024-04741-w

BibTeX
@article{Sato2025,
  author = {Sato, Miki Takenaka and Araki, Takuya and Yashima, Hideaki and Ishikawa, Yuya and Morita, Jun and Maeda, Yoshiko and Ohbayashi, Masayuki and Kohyama, Noriko and Ogawa, Yoshio and Fukagai, Takashi and Yamamoto, Koujirou and Kogo, Mari},
  title = {Variations in serum concentrations of sunitinib and its metabolites in patients receiving long-term sunitinib treatment},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2025},
  volume = {95},
  number = {1},
  doi = {10.1007/s00280-024-04741-w}
}
Kostenlos starten →